Clinical Study Results
Adverse events
There were 27.8% of participants who had adverse events during the study. This
was 10 out of 36 participants.
The table below shows how many participants had adverse events during the study.
Adverse events during the study
10 mg of 30 mg of 100 mg of
benralizumab benralizumab benralizumab
(out of 12 (out of 12 (out of 12
participants) participants) participants)
How many participants had
25.0% (3) 41.7% (5) 16.7% (2)
adverse events?
How many participants had
0.0% (0) 0.0% (0) 8.3% (1)
serious adverse events?
How many participants left
the study due to adverse 0.0% (0) 0.0% (0) 0.0% (0)
events?
5